Stay updated on Nivolumab vs. Everolimus in RCC: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs. Everolimus in RCC: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The access-denied page is replaced by the study record, displaying details about the nivolumab-versus-everolimus trial, including its design, eligibility criteria, outcomes, and study history.
    Difference
    100%
    Check dated 2026-11-09T13:52:11.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site footer revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T15:48:50.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T14:57:32.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s displayed site revision changed from v3.7.1 to v3.7.2. The page still shows a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-19T14:46:49.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:43:36.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Access to the study page is blocked, displaying a 403 Forbidden error. The page shows standard site chrome and a Home link, indicating the study record is not currently accessible.
    Difference
    0.5%
    Check dated 2026-09-28T19:05:01.000Z thumbnail image

Stay in the know with updates to Nivolumab vs. Everolimus in RCC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs. Everolimus in RCC: Clinical Trial page.